Outrage as New ‘Coronavirus’ Treatment Comes with a Hefty Price Tag of Up to Almost €4,000

The first medication which has been released and marketed to exclusively treat the Covid-19 virus, Remdesivir, comes with a hefty price tag.

THE drug, created by the American pharmaceutical company Gilead, announced that governments in developed countries could expect to pay $390 for a vial, which would equate to around €2,082 per patient and longer therapies could cost up to €3,818.

Hospitals have been using this medication, which was donated by Gilead, since May but they will begin charging for their services in July. This is the first drug approved by the European Medicine Agency as a Covid-19 remedy.

The drug is expected to shorten recovery time and stems from an experimental therapy that began in 2009 to try and treat Ebola. The drug is an antiviral medicine which slows down the production of new particles, and therefore the illness develops less quickly and patients recover an average of four days earlier than usual.